VON GUNTEN STEPHAN,WEHRLI MARC,ZÜRCHER ADRIAN,MIESCHER SYLVIA
申请号：
NZ61089111
公开号：
NZ610891A
申请日:
2011.12.14
申请国别(地区):
NZ
年份:
2015
代理人:
摘要：
Discloses use of a CD89-activating molecule in the manufacture of a medicament for the treatment of an autoimmune disorder or inflammatory condition by inducing apoptosis in neutrophils, wherein the CD89-activating molecule is a soluble molecule comprising Fc-alpha or a functional equivalent thereof.
